Drug – bio-affecting and body treating compositions – Whole live micro-organism – cell – or virus containing
Reexamination Certificate
2005-03-01
2005-03-01
Navarro, Mark (Department: 1645)
Drug, bio-affecting and body treating compositions
Whole live micro-organism, cell, or virus containing
C424S093400, C424S093450, C424S114000, C424S116000, C424S184100, C514S002600
Reexamination Certificate
active
06861053
ABSTRACT:
Disclosed is a method of diagnosing irritable bowel syndrome, fibromyalgia, chronic fatigue syndrome, depression, attention deficit/hyperactivity disorder, autoimmune diseases, such as multiple sclerosis and systemic lupus erythematosus, or Crohn's disease, which involves detecting the presence of small intestinal bacterial overgrowth (SIBO) in a human subject having at least one symptom associated with a suspected diagnosis of any of those diagnostic categories. Also disclosed is a method of treating these disorders, and other disorders caused by SIBO, that involves at least partially eradicating a SIBO condition in the human subject. The method includes administration of anti-microbial or probiotic agents, or normalizing intestinal motility by employing a prokinetic agent. The method improves symptoms, including hyperalgesia related to SIBO and disorders caused by SIBO. Also disclosed is a kit for the diagnosis or treatment of irritable bowel syndrome, fibromyalgia, chronic fatigue syndrome, depression, attention deficit/hyperactivity disorder, autoimmune diseases, or Crohn's disease.
REFERENCES:
patent: 4673680 (1987-06-01), Pendleton
patent: 4970207 (1990-11-01), Sato et al.
patent: 5041431 (1991-08-01), Halskov
patent: 5120306 (1992-06-01), Gosselin
patent: 5219871 (1993-06-01), Cross et al.
patent: 5225352 (1993-07-01), Zanetta et al.
patent: 5236901 (1993-08-01), Burks et al.
patent: 5380522 (1995-01-01), Day
patent: 5426028 (1995-06-01), Levy et al.
patent: 5434174 (1995-07-01), Gidda et al.
patent: 5443826 (1995-08-01), Borody
patent: 5453428 (1995-09-01), Kaminski
patent: 5519014 (1996-05-01), Borody
patent: 5538856 (1996-07-01), Levy et al.
patent: 5547961 (1996-08-01), Ohta et al.
patent: 5550132 (1996-08-01), Benson et al.
patent: 5589168 (1996-12-01), Allen et al.
patent: 5599795 (1997-02-01), McCann et al.
patent: 5612366 (1997-03-01), Becker et al.
patent: 5627200 (1997-05-01), Kreutter et al.
patent: 5645997 (1997-07-01), Kline et al.
patent: 5648355 (1997-07-01), Theoharides
patent: 5648359 (1997-07-01), Ohashi et al.
patent: 5660828 (1997-08-01), Rodriguez et al.
patent: 5668143 (1997-09-01), Ku et al.
patent: 5677326 (1997-10-01), Tsuchiya et al.
patent: 5679684 (1997-10-01), Benson et al.
patent: 5684017 (1997-11-01), Harrison et al.
patent: 5691343 (1997-11-01), Sandborn et al.
patent: 5703100 (1997-12-01), McDonald et al.
patent: 5707642 (1998-01-01), Yue
patent: 5726187 (1998-03-01), Gaster et al.
patent: 5728380 (1998-03-01), Allen et al.
patent: 5736560 (1998-04-01), Cosford et al.
patent: 5753218 (1998-05-01), Smith et al.
patent: 5759546 (1998-06-01), Weinberg et al.
patent: 5780026 (1998-07-01), Yoshii et al.
patent: 5821259 (1998-10-01), Theoharides
patent: 5830668 (1998-11-01), Mordechai et al.
patent: 5833987 (1998-11-01), Noelle et al.
patent: 5834215 (1998-11-01), Garry et al.
patent: 5846933 (1998-12-01), Korngold et al.
patent: 5852041 (1998-12-01), Cosford et al.
patent: 5858403 (1999-01-01), Borody et al.
patent: 5863529 (1999-01-01), Rodriguez
patent: 5869262 (1999-02-01), Gallatin et al.
patent: 20020018809 (2002-02-01), Stoll
patent: 20030050308 (2003-03-01), Brunner et al.
patent: 20030124566 (2003-07-01), Kong et al.
patent: 20030152919 (2003-08-01), Roelens et al.
patent: 20030185754 (2003-10-01), Cohen et al.
patent: 20030215421 (2003-11-01), McDonald et al.
Weilman et al (Klin Wochenstr vol. 60 No. 7, pp 371-374), 1982.
Friedman (Gastroenterology Clinics of N. America vol. 20, No. 2, pp 313-324), 1991.
Way et al (Current Surgical Diagnosis & Treatment, 9thEd. p. 1083), 1991.*
Annese, V. et al..,Gastrointestinal motility disorders in patients with inactive Crohn's disease, Scand J Gastroenterol, 32(11):1107-17 (Nov. 1997). Abstract Only.
Autschbach, F. et al.,In situ expression of interleukin-10 in noninflamed human gut and in inflammatory bowel disease, Am J Pathol, 153(1):121-30 (Jul. 1998). Abstract Only.
Alander, M. et al.,The effect of probiotic strains on the microbiota of the Simulator of the Human Intestinal Microbial Ecosystem(SHIME),Int J Food Microbiol, 46(1):71-9 (Jan. 12, 1999). Abstract Only.
Alpert, J.E. et al.,Attention deficit hyperactivity disorder in childhood among adults with major depression, Psychiatry Res, 62(3):213-9 (Jun. 1, 1999). Abstract Only.
Babyatsky, M.W. et al.,Expression of transforming growth factors alpha and beta in colonic mucosa in inflammatory bowel disease, Gastroenterology, 110(4):975-84 (Apr. 1996). Abstract Only.
Bell, Iris R. et al.,Illness from Low Levels of Enviromental Chemicals: Relevance to Chronic Fatigue Syndrome and Fibromyalgia, The American Journal of Medicine, vol. 105 (3A), pp. 74S-82S (Sep. 28, 1998).
Bennett, G. et al.,Nerve growth factor induced hyperalgesia in the rat hind paw is dependent on circulating neutrophils, Pain, 77:315-322 (1998).
Bjornsson, E. S.,comparison between physiologic and erythromycin-induced interdigestive motility, Scand J. Gastroenterol, 30(2):139-45 (Feb. 1995). Abstract Only.
Bruin, K. F. et al.,Modulation of cytokine release from human monocytes by drugs used in the therapy of inflammatory bowel diseases, Eur J. Gastroenterol Hepatol, 7(8):791-5 (Aug. 1995). Abstract Only.
Bruno, Richard L. et al.,Parallels Between Post-Polio Fatigue and Chronic Fatigue Syndrome: A Common Pathophysiology?, The American Journal of Medicine, 105(3A):66A-73S (1998).
Camoglio, L. et al.,Altered expression of interferon-gamma and interleukin-4 in inflammatory bowel disease, Inlfamm Bowel Dis, 4(4):285-90 (Nov. 1998). Abstract Only.
Casafont, Morencos F. et al.,Small bowel bactrial overgrowth in patinets with alcholic cirrhosis, Dig Dis Sci, 41(3):552-6 (Mar. 1996). Abstract Only.
Casini-Raggi, V. et al.,Mucosal imbalance of IL-1 and IL-1 receptor antagonist in inflammatory bowel disease. A novel mechanism of chronic intestinal inflamation, J Immunol, 154(5):2434-40 (Mar. 1, 1995). Abstract Only.
Castedal M.,Postprandial peristalsis in the human duodenum, Neurogastroenterol Motil, 10(3):227-33 (Jun. 1998). Abstract Only.
Chang C. S., et al.,Small intestine dysmotility and bacterial overgrowth in cirrhotic patinets with spontaneous bacterial peritonitis, Hepatology, 28(5):1187-90 (Nov. 1998). Abstract Only.
Chang, C. S.,Increased accuracy of the carbon-14 D-xylose breath test in detecting small-intestinal bacterial overgrowth by correction with the gastric emptying rate, Eur J Nucl Med, 22 (10):1118-22 (Oct. 1995), Abstract Only.
Chesta, J.,Abnormalities in proximal small bowel motility in patients with cirrhosis, Hepatology, 17(5):828-32 (May 1993). Abstract Only.
Cominelli, F.,Interleukin-1 and interleukin-1 receptor antagonist in inflammatory bowel disease, Aliment Pharmacol Ther, 10 Suppl 2:49-53; discussion 54 (1996). Abstract Only.
Corazza, G. R.,The diagnosis of small bowel bacterial overgrowth. Reliability of jejunal culture and inadequacy of breath hydrogen testing, Gastroenterology, 98(2):302-9 (Feb 1990). Abstract Only.
Corazza, G.,Prevalence and consistency of low breath H2 excretion following lactulose ingestion. Possible implications for the clinical use of the H2 breath test Dig dis Sci38(11):2010-6 (Nov. 1993). Abstract Only.
Daig, R. et al.,Increased interleukin 8 expression in colon mucosa of patients with inflammatory bowel disease, Gut, 38(2):216-22 (Feb 1996). Abstract Only.
Dantzer, Robert et al.,Cytokines and Sickness Behavior, Annals New York Academy of Sciences, vol. 840, pp. 586-590 (May 1, 1998).
De Becker, Pascale, et al.,Autonomic Testing in Patients with Chronic Fatigue Syndrome, The American Journal of Medicine, vol. 105(3A), pp. 22S-26S (Sep. 28, 1998).
de Boissieu, D., et al.,Small-bowel bacterial overgrowth in children with chronic diarrhea, abdominal pain, or both, The Journal of Pediatrics, vol. 128, No. 2, pp. 203-207 (Feb. 1996).
de Campos, R. O. P. et al.,Systemic treatment with Mycobacterium bovis bacillus calmette-guérin(BCG)potentiates kinin B, receptor agaonist-induced nociception and oedeme formation in the formalin test in mice, Neuropeptides, vol. 32 No. 5, pp. 393-403 (1998).
Dellert, S. F. et al.,the 13C-xylose
Lin Henry C.
Pimentel Mark
Cedars-Sinai Medical Center
Navarro Mark
Pillsbury & Winthrop LLP
LandOfFree
Methods of diagnosing or treating irritable bowel syndrome... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Methods of diagnosing or treating irritable bowel syndrome..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods of diagnosing or treating irritable bowel syndrome... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3414796